These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15206098)

  • 1. Magnetic resonance contrast agents for medical and molecular imaging.
    Allen MJ; Meade TJ
    Met Ions Biol Syst; 2004; 42():1-38. PubMed ID: 15206098
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance contrast agents in the evaluation of the musculoskeletal system.
    Bloem JL; Reiser MF; Vanel D
    Magn Reson Q; 1990 Apr; 6(2):136-63. PubMed ID: 2202423
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of diethylenetriaminepentaacetic acid-manganese(II) complexes modified by narrow molecular weight distribution of chitosan oligosaccharides as potential magnetic resonance imaging contrast agents.
    Huang Y; Zhang X; Zhang Q; Dai X; Wu J
    Magn Reson Imaging; 2011 May; 29(4):554-60. PubMed ID: 21277723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance tomography of the whole body--methodology and clinical results].
    Sandring KH; Lüning M
    Z Arztl Fortbild (Jena); 1990; 84(24):1259-63. PubMed ID: 2091400
    [No Abstract]   [Full Text] [Related]  

  • 6. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
    Beltran J; Chandnani V; McGhee RA; Kursunoglu-Brahme S
    AJR Am J Roentgenol; 1991 Mar; 156(3):457-66. PubMed ID: 1899738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
    Pui MH; Goh PS; Choo HF; Fok EC
    Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxometry of magnetic resonance imaging contrast agents.
    Koenig SH; Brown RD
    Magn Reson Annu; 1987; ():263-86. PubMed ID: 3079341
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals.
    Hillengass J; Stieltjes B; Bäuerle T; McClanahan F; Heiss C; Hielscher T; Wagner-Gund B; Habetler V; Goldschmidt H; Schlemmer HP; Delorme S; Zechmann CM
    Acta Radiol; 2011 Apr; 52(3):324-30. PubMed ID: 21498370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents for magnetic resonance imaging.
    Wolf GL; Burnett KR; Goldstein EJ; Joseph PM
    Magn Reson Annu; 1985; ():231-66. PubMed ID: 3939977
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
    Mohs AM; Lu ZR
    Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance tomography using the contrast preparation Magnevist].
    Tiutin LA; Panfilenko AF; Arzumanova NV; Fedotova IG; Berezin SM; Shelkoplias EN
    Vestn Rentgenol Radiol; 1996; (2):6-13. PubMed ID: 8754114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic effectiveness of gadolinium-enhanced MR imaging in evaluation of abnormal bone marrow signal.
    Mosher TJ
    Radiology; 2002 Aug; 224(2):320-2. PubMed ID: 12147821
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U; Semelka RC
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midfield and low-field magnetic resonance imaging of the spine.
    Rothschild PA; Winkler ML; Grönemeyer DH; Kaufman L; D'Amour P
    Top Magn Reson Imaging; 1988 Dec; 1(1):11-23. PubMed ID: 3078534
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contrast-enhanced magnetic resonance imaging in the diagnosis of urinary tract disease].
    Shimanovskiĭ NL; Napolov IuK
    Vestn Rentgenol Radiol; 2005; (4):47-56. PubMed ID: 16353902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.